rs76334696
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The ENST00000242317.9(DNAI1):c.1604C>A(p.Thr535Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00654 in 1,614,238 control chromosomes in the GnomAD database, including 278 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T535A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000242317.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1604C>A | p.Thr535Asn | missense_variant | 17/20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.1616C>A | p.Thr539Asn | missense_variant | 17/20 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1604C>A | p.Thr535Asn | missense_variant | 17/20 | 1 | NM_012144.4 | ENSP00000242317 |
Frequencies
GnomAD3 genomes AF: 0.00763 AC: 1162AN: 152238Hom.: 29 Cov.: 32
GnomAD3 exomes AF: 0.0154 AC: 3861AN: 251334Hom.: 102 AF XY: 0.0168 AC XY: 2277AN XY: 135838
GnomAD4 exome AF: 0.00643 AC: 9395AN: 1461882Hom.: 249 Cov.: 32 AF XY: 0.00771 AC XY: 5605AN XY: 727240
GnomAD4 genome AF: 0.00761 AC: 1160AN: 152356Hom.: 29 Cov.: 32 AF XY: 0.00985 AC XY: 734AN XY: 74504
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:4
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Thr535Asn in exon 17 of DNAI1: This variant is not expected to have clinical sig nificance because it has been identified in 5.9% (11/186) of Finnish chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.go v/projects/SNP; dbSNP rs76334696). - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 23, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at